Brain inflammation and cognitive decline induced by spinal cord injury can be reversed by spinal cord cell transplants
Brain, Behavior, and Immunity · 2025
DOI: 10.1016/j.bbi.2025.01.014 ↗Kurz gefasst
Fachartikel in der Zeitschrift Brain, Behavior, and Immunity, 2025. Verfasst von Quentin Delarue und 9 weiteren Autor:innen. Beteiligte Einrichtung: Univ Rouen Normandie, Normandie Univ, GRHVN UR 3830, F-76000 Rouen, France; Université Paris Cité, CNRS UMR8003, Saints-Pères Paris Institute for Neu…. Hauptthemen laut MEDLINE: Spinal Cord Injuries, Cognitive Dysfunction, Neuroinflammatory Diseases, Encephalitis. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Fondation de l'Avenir pour la Recherche Médicale Appliquée.
Abstract (Originalsprache)
Spinal cord injuries (SCIs) impact between 250,000 and 500,000 people worldwide annually, often resulting from road accidents or falls. These injuries frequently lead to lasting disabilities, with the severity depending on the injury's extent and location. Emerging research also links SCIs to cognitive impairments due to brain inflammation. From a treatment perspective, various approaches, including cell therapy, have been investigated. One common mechanism across cellular transplant models is the modulation of inflammation at the injury site, though it remains uncertain if these effects extend to the brain. To explore this, we induced SCI in wild-type mice and treated them with either olfactory ensheathing cells or mesenchymal stem cells. Our findings reveal that both cell types can reverse SCI-induced cognitive deficits, reduce brain inflammation, and increase hippocampal neuronal density. This study is the first, to our knowledge, to demonstrate that cells transplanted into the spinal cord can influence brain inflammation and mitigate injury-induced effects on brain functions. These results highlight the intricate relationship between the spinal cord and brain in both health and disease.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Univ Rouen Normandie, Normandie Univ, GRHVN UR 3830, F-76000 Rouen, France; Université Paris Cité, CNRS UMR8003, Saints-Pères Paris Institute for Neurosciences, F-75006 Paris, France. Electronic address: quentindelarue.…
- Univ Rouen Normandie, Normandie Univ, GRHVN UR 3830, F-76000 Rouen, France.
- Université Paris Cité, CNRS UMR8003, Saints-Pères Paris Institute for Neurosciences, F-75006 Paris, France.
- Normandie Univ, UNIROUEN, Inserm, U1234, FOCIS Center of Excellence, Pan'THER, F-76000 Rouen, France; Centre Henri Becquerel, Department of Pharmacy, F-76000 Rouen, France.
- Normandie Univ, UNIROUEN, Inserm, U1234, FOCIS Center of Excellence, Pan'THER, F-76000 Rouen, France.
- Université Paris Cité, CNRS UMR8003, Saints-Pères Paris Institute for Neurosciences, F-75006 Paris, France. Electronic address: nicolas.guerout@u-paris.fr.
Förderung
- Fondation de l'Avenir pour la Recherche Médicale Appliquée
Zitieren
APA
Delarue, Q., Robac, A., Semprez, F., Duclos, C., Pileyre, B., Neveu, P., Raimond, C., Riou, G., Ziane, I., & Guérout, N. (2025). Brain inflammation and cognitive decline induced by spinal cord injury can be reversed by spinal cord cell transplants. Brain, Behavior, and Immunity. https://doi.org/10.1016/j.bbi.2025.01.014
Vancouver
Delarue Q, Robac A, Semprez F, Duclos C, Pileyre B, Neveu P, et al. Brain inflammation and cognitive decline induced by spinal cord injury can be reversed by spinal cord cell transplants. Brain, Behavior, and Immunity. 2025. doi:10.1016/j.bbi.2025.01.014
BibTeX
@article{Delarue2025,
author = {Delarue, Quentin and Robac, Amandine and Semprez, Fannie and Duclos, Célia and Pileyre, Baptiste and Neveu, Pauline and Raimond, Clémence and Riou, Gaëtan and Ziane, Inès and Guérout, Nicolas},
title = {Brain inflammation and cognitive decline induced by spinal cord injury can be reversed by spinal cord cell transplants},
journal = {Brain, Behavior, and Immunity},
year = {2025},
doi = {10.1016/j.bbi.2025.01.014}
}
EUVIMED